A Phase III, International, Randomized, Controlled Study

Project: Research project

Project Details

Description

A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physicians Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent
StatusActive
Effective start/end date12/31/157/1/21

Funding

  • ONCONOVA THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.